Case 23-2012: A Man with Abdominal Pain and Weight Loss
New England Journal of Medicine (Impact Factor: 55.87). 10/2012; 367(17):1670; author reply 1671-2. DOI: 10.1056/NEJMc1210168#SA1
To the Editor: With regard to the Case Record by Xavier et al. (July 26 issue),(1) which discusses the diagnosis of strongyloidiasis: I am concerned about proceeding with upper and lower gastrointestinal endoscopic investigations after identifying numerous rhabditiform larvae of Strongyloides stercoralis in a stool specimen obtained from a patient. On the basis of the typical clinical manifestations that are compatible with strongyloidiasis,(2) such patients could receive ivermectin as the treatment of choice for this potentially fatal parasitic infection. Endoscopic procedures could cause complications, including perforation and toxic megacolon, and they are unlikely to alter therapeutic decision making. To the . . .
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.